Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
25.74
+0.56 (2.22%)
At close: Mar 27, 2026
HKG:2252 Revenue
In the year 2025, Shanghai MicroPort MedBot (Group) had annual revenue of 551.07M CNY with 114.22% growth. Shanghai MicroPort MedBot (Group) had revenue of 375.38M in the half year ending December 31, 2025, with 558.69% growth.
Revenue
551.07M CNY
Revenue Growth
+114.22%
P/S Ratio
43.29
Revenue / Employee
1.25M CNY
Employees
440
Market Cap
26.55B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 551.07M | 293.82M | 114.22% |
| Dec 31, 2024 | 257.25M | 152.66M | 145.95% |
| Dec 31, 2023 | 104.59M | 82.99M | 384.15% |
| Dec 31, 2022 | 21.60M | 19.45M | 904.79% |
| Dec 31, 2021 | 2.15M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Isotope & Radiation | 8.35B |
| MicroPort Scientific | 8.01B |
| AK Medical Holdings | 1.65B |
| LifeTech Scientific | 1.45B |
| Zylox-Tonbridge Medical Technology | 1.18B |
| Beijing Chunlizhengda Medical Instruments | 1.16B |
| MicroPort NeuroScientific | 879.66M |
| Peijia Medical | 793.29M |
Shanghai MicroPort MedBot (Group) News
- 2 months ago - AI surgery: Chinese robot conducts complex operation on pig without human intervention - South China Morning Post